Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-02

Clinical Trial Update: A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of vildagliptin and metformin in patients with type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vildagliptin (vildagliptin)
  • metformin (metformin)

Snippet

Sponsor: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | Conditions: TYpe 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED